COVID-19
COVID-19 frontline

How to use Tocilizumab to reduce mortality of severe patients?

cgtn.com | Updated: 2020-04-26 14:11

Fu Binqing, a professor at the University of Science and Technology of China, shared the results of her research on the use of Tocilizumab to reduce the mortality of severe COVID-19 patients with doctors from Canada and the US via a conference call on April 20.

Please feel free to contact us by sending your questions to question@chinadaily.com.cn or commenting on China Daily app. We will ask experts to answer them.

Editor's picks
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US